Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Garbe

Showing results (11-20 of 500) with videos related to

Pageof 50
Sort By:
Advances in Experimental Medicine and Biology|March 20, 2008
Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlightUlrike Leiter, Claus Garbe
Annals of Translational Medicine|February 3, 2017
Acquired resistance mechanisms to immunotherapyTeresa Amaral, Claus Garbe
Expert Opinion on Biological Therapy|February 23, 2016
Intralesional immunotherapy as a strategy to treat melanomaNoura Nouri, Claus Garbe
Expert Opinion on Pharmacotherapy|April 18, 2017
Non-melanoma skin cancer: new and future synthetic drug treatmentsTeresa Amaral, Claus Garbe
Pigment Cell Research|May 20, 2003
Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological dataJürgen Bauer, Claus Garbe
Clinics in Dermatology|December 20, 2008
Melanoma epidemiology and trendsClaus Garbe, Ulrike Leiter
Expert Opinion on Pharmacotherapy|August 17, 2017
Reply to 'Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma'Teresa Amaral, Claus Garbe
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
VemurafenibClaus Garbe, Thomas K Eigentler
Melanoma Research|May 15, 2007
Diagnosis and treatment of cutaneous melanoma: state of the art 2006Claus Garbe, Thomas K Eigentler
Immunotherapy|March 27, 2020
Updates and new perspectives in nonmelanoma skin cancer therapy: highlights from 'Immunotherapy Bridge'Paolo Antonio Ascierto, Claus Garbe
Pageof 50

Showing results (11-20 of 500) with videos related to

Sort By:
Pageof 50
Advances in Experimental Medicine and Biology|March 20, 2008
Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlightUlrike Leiter, Claus Garbe
Annals of Translational Medicine|February 3, 2017
Acquired resistance mechanisms to immunotherapyTeresa Amaral, Claus Garbe
Expert Opinion on Biological Therapy|February 23, 2016
Intralesional immunotherapy as a strategy to treat melanomaNoura Nouri, Claus Garbe
Expert Opinion on Pharmacotherapy|April 18, 2017
Non-melanoma skin cancer: new and future synthetic drug treatmentsTeresa Amaral, Claus Garbe
Pigment Cell Research|May 20, 2003
Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological dataJürgen Bauer, Claus Garbe
Clinics in Dermatology|December 20, 2008
Melanoma epidemiology and trendsClaus Garbe, Ulrike Leiter
Expert Opinion on Pharmacotherapy|August 17, 2017
Reply to 'Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma'Teresa Amaral, Claus Garbe
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
VemurafenibClaus Garbe, Thomas K Eigentler
Melanoma Research|May 15, 2007
Diagnosis and treatment of cutaneous melanoma: state of the art 2006Claus Garbe, Thomas K Eigentler
Immunotherapy|March 27, 2020
Updates and new perspectives in nonmelanoma skin cancer therapy: highlights from 'Immunotherapy Bridge'Paolo Antonio Ascierto, Claus Garbe
Pageof 50